NASDAQ : DXR
Daxor Corporation — Financial statements
Healthcare · Medical Instruments & Supplies · United States
Last price 8.92 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 52.08M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Daxor Corporation (DXR) reported revenue of 31.36K USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Other Revenue | 31.36K | 26.69K | 119.71K | 163.42K | 231.64K | 278.09K |
| Revenue | 31.36K | 26.69K | 119.71K | 163.42K | 231.64K | 278.09K |
| Gross Profit | 31.36K | 26.69K | 119.71K | 163.42K | 231.64K | 278.09K |
| Selling, General & Admin | 337.30K | 327.13K | 294.19K | 307.36K | 1.09M | 991.31K |
| Other Operating Expenses | 8.84K | 16.29K | 16.74K | 12.40K | 5.89K | 32.36K |
| Operating Expenses | 1.88M | 1.11M | 1.56M | 951.47K | 1.09M | 1.02M |
| Operating Income | -1.85M | -1.08M | -1.44M | -788.04K | -859.73K | -745.58K |
| Interest Expense | -3.35K | -15.96K | -85.09K | -49.10K | -72.45K | -19.61K |
| Other Non Operating Income (Expenses) | -2.50M | -292.95K | -1.65M | 33.77M | -97.74K | 23.96K |
| EBT Excluding Unusual Items | -4.35M | -1.39M | -3.17M | 32.94M | -1.03M | -741.22K |
| Gain (Loss) on Sale of Investments | 10.58M | 10.56M | 3.71M | -32.66M | 6.21M | 5.49M |
| Pretax Income | 6.23M | 9.17M | 536.33K | 280.64K | 5.18M | 4.75M |
| Net Income | 6.23M | 9.17M | 536.33K | 280.64K | 5.18M | 4.75M |
| Net Income to Common | 6.23M | 9.17M | 536.33K | 280.64K | 5.18M | 4.75M |
| Shares Outstanding (Basic) | 5.84M | 5.06M | 4.93M | 4.81M | 4.29M | 4.04M |
| Shares Outstanding (Diluted) | 5.84M | 5.06M | 4.93M | 4.81M | 4.29M | 4.04M |
| EPS (Basic) | 1.07 | 1.81 | 0.11 | 0.06 | 1.21 | 1.18 |
| EPS (Diluted) | 1.07 | 1.81 | 0.11 | 0.06 | 1.21 | 1.18 |
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% |
| Operating Margin | -5,894.33% | -4,056.67% | -1,200.19% | -482.21% | -371.15% | -268.11% |
| Profit Margin | 19,861.41% | 34,359.17% | 448.01% | 171.73% | 2,235.41% | 1,707.43% |
| EBIT | -1.85M | -1.08M | -1.44M | -788.04K | -859.73K | -745.58K |
| EBIT Margin | -268.11% | |||||
| Revenue as Reported | 31.36K | 26.69K | 119.71K | 163.42K | 231.64K | 278.09K |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Accounts Receivable | 9.68K | 14.20K | 17.23K | 30.70K | ||
| Receivables | 9.68K | 14.20K | 17.23K | 30.70K | ||
| Prepaid Expenses | 68.03K | 9.86K | 8.89K | 11.68K | 20.61K | 23.10K |
| Restricted Cash | 710.70K | |||||
| Total Current Assets | 68.03K | 9.86K | 18.57K | 25.88K | 37.84K | 764.50K |
| Long-Term Investments | 51.79M | 46.00M | 36.61M | 34.84M | 30.22M | 24.22M |
| Total Assets | 51.86M | 46.01M | 36.63M | 34.87M | 30.26M | 24.98M |
| Accounts Payable | 23.60K | 112.00K | 110.33K | 103.10K | 62.44K | 87.40K |
| Short-Term Debt | 715.80K | |||||
| Current Income Taxes Payable | 10.60K | |||||
| Other Current Liabilities | 3.23K | |||||
| Total Current Liabilities | 23.60K | 122.59K | 110.33K | 103.10K | 62.44K | 806.42K |
| Long-Term Debt | 729.97K | 755.66K | 1.23M | 3.02M | ||
| Total Liabilities | 23.60K | 122.59K | 840.30K | 858.76K | 1.29M | 3.83M |
| Common Stock | 63.13K | 55.35K | 54.09K | 53.17K | 53.17K | 53.17K |
| Additional Paid-In Capital | 24.78M | 15.53M | 14.61M | 13.69M | 12.90M | 12.11M |
| Retained Earnings | 31.49M | 34.80M | 25.63M | 25.09M | 24.79M | 19.61M |
| Treasury Stock | -4.50M | -4.50M | -4.50M | -4.83M | -8.77M | -10.62M |
| Shareholders' Equity | 51.83M | 45.89M | 35.79M | 34.01M | 28.97M | 21.15M |
| Total Liabilities & Equity | 51.86M | 46.01M | 36.63M | 34.87M | 30.26M | 24.98M |
| Total Debt | 729.97K | 755.66K | 1.23M | 3.74M | ||
| Net Cash (Debt) | -729.97K | -755.66K | -1.23M | -3.74M | ||
| Net Cash Per Share | -0.15 | -0.16 | -0.29 | -0.93 | ||
| Filing Date Shares Outstanding | 5.84M | 5.06M | 4.93M | 4.81M | 4.29M | 4.04M |
| Total Common Shares Outstanding | 5.84M | 5.06M | 4.93M | 4.81M | 4.29M | 4.04M |
| Working Capital | 44.44K | -112.73K | -91.76K | -77.22K | -24.60K | -41.93K |
| Book Value Per Share | 8.88 | 9.07 | 7.25 | 7.08 | 6.75 | 5.24 |
| Tangible Book Value | 51.83M | 45.89M | 35.79M | 34.01M | 28.97M | 21.15M |
| Tangible Book Value Per Share | 8.88 | 9.07 | 7.25 | 7.08 | 6.75 | 5.24 |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | 6.23M | 9.17M | 536.33K | 280.64K | 5.18M | 4.75M |
| Loss (Gain) From Sale of Investments | -10.58M | -10.56M | -2.10M | -1.17M | -6.21M | -5.49M |
| Stock-Based Compensation | 1.53M | 765.91K | 1.25M | 631.70K | 786.64K | 729.34K |
| Other Operating Activities | -5.37M | 1.18M | 325.95K | -3.45M | -517.01K | -2.96M |
| Change in Accounts Receivable | 1.81K | 9.70K | 4.52K | 3.04K | 13.47K | -1.40K |
| Change in Accounts Payable | 7.40K | |||||
| Change in Other Net Operating Assets | 13.07K | 11.53K | 9.57K | 49.59K | -22.47K | |
| Operating Cash Flow | -8.18M | 570.94K | 25.69K | -3.66M | -769.30K | -2.76M |
| Long-Term Debt Issued | 691.83K | 2.03M | 4.11M | 4.08M | 3.71M | |
| Long-Term Debt Repaid | -1.42M | -2.05M | -4.59M | -5.87M | -856.62K | |
| Net Debt Issued (Repaid) | -263.18K | -730.22K | -25.69K | -473.51K | -1.79M | 2.85M |
| Issuance of Common Stock | 9.17M | 159.28K | 4.53M | 1.85M | ||
| Repurchase of Common Stock | -401.27K | |||||
| Financing Cash Flow | 8.18M | -570.94K | -25.69K | 3.66M | 58.60K | 2.85M |
| Net Cash Flow | -710.70K | 92.90K | ||||
| Levered Free Cash Flow | 333.87K | 100.25K | 308.95K | 161.10K | 902.49K | 378.21K |
| Unlevered Free Cash Flow | 335.96K | 110.22K | 362.13K | 191.79K | 947.78K | 390.47K |
| Cash Interest Paid | 3.35K | 15.96K | 85.09K | 49.10K | 72.45K | 19.61K |
| Cash Income Tax Paid | 4.40K | 3.48K | 13.80K | 9.71K | 30.39K | |
| Change in Working Capital | 14.88K | 21.23K | 14.09K | 52.62K | -9.01K | 216.79K |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 52.60M | 73.52M | 37.22M | 46.01M | 39.05M | 45.52M |
| Enterprise Value | 52.92M | 73.78M | 38.87M | 47.24M | 41.85M | 47.67M |
| Last Close Price | 9.20 | 14.75 | 7.69 | 9.60 | 9.16 | 11.29 |
| PE Ratio | 8.45 | 8.02 | 69.40 | 163.93 | 7.54 | 9.59 |
| Forward PE | 44.52 | 44.52 | 44.52 | 44.52 | 44.52 | |
| PS Ratio | 1,710.88 | 2,754.82 | 310.91 | 281.52 | 168.57 | 163.70 |
| PB Ratio | 1.04 | 1.60 | 1.04 | 1.35 | 1.35 | 2.15 |
| P/TBV Ratio | 1.04 | 1.60 | 1.04 | 1.35 | 1.35 | 2.15 |
| P/OCF Ratio | 128.77 | 1,448.70 | ||||
| EV/Sales Ratio | 1,721.13 | 2,764.67 | 324.69 | 289.04 | 180.65 | 171.42 |
| Debt / Equity Ratio | 0.02 | 0.02 | 0.04 | 0.18 | ||
| Net Debt / Equity Ratio | 0.02 | 0.02 | 0.04 | 0.18 | ||
| Asset Turnover | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 |
| Quick Ratio | 0.09 | 0.14 | 0.28 | 0.04 | ||
| Current Ratio | 2.88 | 0.08 | 0.17 | 0.25 | 0.61 | 0.95 |
| Return on Equity (ROE) | 14.24% | 22.45% | 1.54% | 0.89% | 20.66% | 25.79% |
| Return on Assets (ROA) | -2.63% | -1.64% | -2.51% | -1.51% | -1.94% | -2.24% |
| Return on Invested Capital (ROIC) | -3.57% | -2.63% | -4.03% | -2.43% | -3.12% | -3.60% |
| Return on Capital Employed (ROCE) | -3.60% | -2.40% | -3.90% | -2.30% | -2.80% | -3.10% |
| Earnings Yield | 11.84% | 12.47% | 1.44% | 0.61% | 13.26% | 10.43% |
| Buyback Yield / Dilution | -17.13% | -2.54% | -2.66% | -12.01% | -6.24% | -0.13% |
| Total Shareholder Return | -17.13% | -2.54% | -2.66% | -12.01% | -6.24% | -0.13% |